Glaxosmithkline Consumer Healthcare [Merged]: Unaudited Financial Results For Quarter Ended December 31 2019

Pursuant to Regulation 33 and 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we would like to inform you that the Board of Directors in its meeting Thursday February 06 2020 at 01:30 p.m. at Board Room One Horizon Centre DLF Phase - V Golf Course Road Gurugram 122002 have inter alia considered and taken on record the Unaudited Financial Results for the Quarter ended December 31 2019.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations 2015 we wish to inform you that Mr. Vivek Anand resigned as Chief Financial Officer w.e.f. October 31 2019 and Mr. Nitin Mathur joined as Head of Finance w.e.f. November 01 2019.

We are enclosing a copy of the Unaudited Financial Results for the Quarter ended December 31 2019 along with the Limited Review Report issued by the Auditors for the review done by them for your records.